Chuan-Tsai Tsai
Overview
Explore the profile of Chuan-Tsai Tsai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao J, Chan Y, Kuo L, Tsai C, Liu C, Chen T, et al.
Eur Heart J Qual Care Clin Outcomes
. 2025 Jan;
PMID: 39844352
Objective: To analyze the temporal trends of oral anticoagulant (OAC) prescription, direct oral anticoagulant (DOAC) dose, clinical outcomes and factors associated with non-anticoagulation in patients with incident atrial fibrillation (AF)....
2.
Liao J, Chan Y, Kuo L, Tsai C, Liu C, Chen T, et al.
Heart Rhythm
. 2024 Aug;
22(2):486-494.
PMID: 39094727
Background: The impact of post-stroke antithrombotic regimen in atrial fibrillation is uncertain. Objective: This study aimed to describe antithrombotic therapy prescribing patterns after ischemic stroke and the impact on outcomes....
3.
Liao J, Huang Y, Tsai C, Kuo L, Chen S, Tuan T, et al.
Rev Cardiovasc Med
. 2024 Jul;
25(3):92.
PMID: 39076938
Background: Gender is a well-recognized risk factor in atrial fibrillation (AF)-related ischemic stroke. The association of gender with the use of oral anticoagulants (OACs) and prognosis remains unknown. Methods: The...
4.
Tsai C, Chan Y, Liao J, Chen T, Lip G, Chen S, et al.
BMC Med
. 2024 Mar;
22(1):113.
PMID: 38475752
Background: In post-stroke atrial fibrillation (AF) patients who have indications for both oral anticoagulant (OAC) and antiplatelet agent (AP), e.g., those with carotid artery stenosis, there is debate over the...
5.
Tsai C, Liao J, Chan Y, Kuo L, Liu C, Lip G, et al.
Int J Cardiol Heart Vasc
. 2024 Feb;
50:101333.
PMID: 38419610
Introduction: Reduced-dose (Low-dose [LD]) apixaban is recommended in patients with atrial fibrillation (AF) who fulfill 2 of 3 criteria: age ≥ 80 years, body weight ≤ 60 kg, and a...
6.
Tsai C, Chan Y, Liao J, Chen T, Lip G, Chen S, et al.
Thromb Haemost
. 2023 Sep;
124(3):253-262.
PMID: 37776848
Background: Dementia and atrial fibrillation (AF) have many shared risk factors. Besides, patients with dementia are under-represented in randomized trials, and even if AF is present, oral anticoagulants (OACs) are...
7.
Lu Y, Tsai C, Chou R, Tsai Y, Kuo C, Huang P, et al.
Sci Rep
. 2023 Jun;
13(1):9652.
PMID: 37316697
Insulin resistance (IR) is associated with cardiovascular disease in non-diabetic patients. The triglyceride-glucose (TyG) index, incorporating serum glucose and insulin concentrations, is a surrogate insulin resistance marker. We investigated its...
8.
9.
Huang S, Huang W, Tsai C, Chen Y, Lee S, Lu T
Sci Rep
. 2023 May;
13(1):7541.
PMID: 37160906
Asymmetric dimethylarginine (ADMA) is considered to be an atherogenic molecule. We aimed to investigate the relationship between ADMA and plaque vulnerability assessed by optical coherence tomography (OCT) in patients with...
10.
Hung C, Chao T, Tsai C, Liao J, Lim S, Tuan T, et al.
JACC Heart Fail
. 2023 Jan;
11(10):1454-1456.
PMID: 36647927
No abstract available.